|1||NCT01637844||Completed||Telbivudine Therapy in HBeAg-positive Pregnant Women to Prevent Mother-to-infant Transmission of HBV||
||335||Female||20 Years to 40 Years (Adult)||NCT01637844||2012019||April 2012||October 2014||October 2014||July 11, 2012||December 2, 2014||
|2||NCT01745822||Active, not recruiting||Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand||
||Other / NIH / U.S. Fed / Industry||
||328||Female||18 Years and older (Adult, Senior)||NCT01745822||U01HD071889||iTAP||January 2013||December 2016||October 2018||December 10, 2012||August 21, 2017||
† Study has passed its completion date and status has not been verified in more than two years.